Stock chart arrow pointing down with a Canadian flag in the background.
(File image)

A drop in oil and gold prices hit commodity stocks, impacting Canada’s main stock index on Wednesday, while data showed inflation accelerated again in June but not as sharply as expected.

Mainly on rising gasoline prices, data showed the country’s annual inflation rate accelerated to 8.1 per cent last month, up from 7.7 per cent in May. This was slightly below market expectations and eased fears of another aggressive move from the central bank.

Wall Street indexes were also turbulent after sharp gains in the previous session, as investors digested earnings reports from companies for any impression of surging inflation on business growth. Uncertainties continue to stem from the conflict in Ukraine, which also weighed on sentiment as Washington said it saw signs Moscow was preparing to formally annex territory it has seized during nearly five months of war.

Today in the Markets

TSX 19,020.67 +82.96 TSX
TSXV 607.10 +0.76 TSXV
CSE 284.84 +5.04 TSXV
DJIA 31,874.44 +47.79 DJIA
NASDAQ 11,897.65 +184.50 NASDAQ
S&P 500 3,959.90 +23.21 S&P 500

The Canadian dollar traded for 77.64 cents US compared to 77.68 cents US on Tuesday.

US crude futures traded 1.54 per cent lower at $102.60 a barrel, while the Brent contract lost 0.57 of a per cent to $106.70 a barrel.

The price of gold was down US$16.01 to US$1,694.59.

In world markets, the Nikkei was up 718.58 to 27,680.26, the Hang Seng was up 229.16 points to 20,890.22, the FTSE was down 33.09 points to 7,263.19, and the DAX was down 26.43 points to 13,281.98.


Get @ the Bell delivered to your email inbox every day!

Sign Up Here





DISCLAIMER: By viewing any material on or distributed by The Market Herald Publishing Ltd. and its Information Providers you agree to both the following disclaimer, and the full disclaimer that can be viewed here.

Any holdings, theories, speculation or trades appearing anywhere on The Market Herald network of websites should not be relied upon for purposes of transacting securities or other investments, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. This applies to any material regardless of source, placement, presentation or reproduction. Any Information Providers to The Market Herald or employees of The Market Herald may from time to time have positions in the stocks or other entities mentioned anywhere on The Market Herald Network of websites. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment. The Market Herald and its contributors makes no guarantee as to the validity of any information, speculation, theories or research presented herein whether pertaining to the past, present or future. The Service and The Materials are provided by The Market Herald and other Information Providers on an “as is” basis, and The Market Herald and other Information Providers expressly disclaim any and all warranties, express or implied, including, without limitation, warranties of satisfactory quality and fitness for a particular purpose, with respect to the service or any materials and products. In no event shall The Market Herald and other Information Providers be liable for any direct, indirect, incidental, punitive, or consequential damages of any kind whatsoever with respect to The Service, The Materials, and The Products.


More From The Market Online
Doctor with a bladder replica

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide

As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
Nervous system

NervGen Pharma: Proof that NVG-291 works?

Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
Santa looking at stock charts

@ the Bell: TSX and S&P 500 ascend into the weekend

Canada’s TSX index added almost 200 points on Friday thanks to gains across industries, including a 23.13 per cent gain from BlackBerry.